» Articles » PMID: 33868271

Microenvironmental Regulation of Macrophage Transcriptomic and Metabolomic Profiles in Pulmonary Hypertension

Abstract

The recruitment and subsequent polarization of inflammatory monocytes/macrophages in the perivascular regions of pulmonary arteries is a key feature of pulmonary hypertension (PH). However, the mechanisms driving macrophage polarization within the adventitial microenvironment during PH progression remain unclear. We previously established that reciprocal interactions between fibroblasts and macrophages are essential in driving the activated phenotype of both cell types although the signals involved in these interactions remain undefined. We sought to test the hypothesis that adventitial fibroblasts produce a complex array of metabolites and proteins that coordinately direct metabolomic and transcriptomic re-programming of naïve macrophages to recapitulate the pathophysiologic phenotype observed in PH. Media conditioned by pulmonary artery adventitial fibroblasts isolated from pulmonary hypertensive (PH-CM) or age-matched control (CO-CM) calves were used to activate bone marrow derived macrophages. RNA-Seq and mass spectrometry-based metabolomics analyses were performed. Fibroblast conditioned medium from patients with idiopathic pulmonary arterial hypertension or controls were used to validate transcriptional findings. The microenvironment was targeted using a fibroblast-macrophage co-culture system and in a mouse model of hypoxia-induced PH. Both CO-CM and PH-CM actively, yet distinctly regulated macrophage transcriptomic and metabolomic profiles. Network integration revealed coordinated rewiring of pro-inflammatory and pro-remodeling gene regulation in concert with altered mitochondrial and intermediary metabolism in response to PH-CM. Pro-inflammation and metabolism are key regulators of macrophage phenotype , and are closely related to flow sorted lung interstitial/perivascular macrophages from hypoxic mice. Metabolic changes are accompanied by increased free NADH levels and increased expression of a metabolic sensor and transcriptional co-repressor, C-terminal binding protein 1 (CtBP1), a mechanism shared with adventitial PH-fibroblasts. Targeting the microenvironment created by both cell types with the CtBP1 inhibitor MTOB, inhibited macrophage pro-inflammatory and metabolic re-programming both and . In conclusion, coordinated transcriptional and metabolic reprogramming is a critical mechanism regulating macrophage polarization in response to the complex adventitial microenvironment in PH. Targeting the adventitial microenvironment can return activated macrophages toward quiescence and attenuate pathological remodeling that drives PH progression.

Citing Articles

Variant Increases the Risk of Developing VEGFR (Vascular Endothelial Growth Factor Receptor) Blocker-Induced Pulmonary Vascular Disease.

Signoretti C, Matsumura S, Fatehi S, DSilva M, Mathew R, Cendali F J Am Heart Assoc. 2024; 13(19):e035174.

PMID: 39291493 PMC: 11681449. DOI: 10.1161/JAHA.123.035174.


Fibroblasts in Pulmonary Hypertension: Roles and Molecular Mechanisms.

Zhang H, Li M, Hu C, Stenmark K Cells. 2024; 13(11.

PMID: 38891046 PMC: 11171669. DOI: 10.3390/cells13110914.


Novel insights and new therapeutic potentials for macrophages in pulmonary hypertension.

Zuo Y, Li B, Gao M, Xiong R, He R, Li N Respir Res. 2024; 25(1):147.

PMID: 38555425 PMC: 10981837. DOI: 10.1186/s12931-024-02772-8.


Role of the Systemic Inflammatory Response Index in Predicting Disease Severity and Prognosis in Idiopathic Pulmonary Arterial Hypertension.

Gao L, Zhang S, Zhao Z, Zhao Q, Yang T, Zeng Q J Inflamm Res. 2024; 17:447-460.

PMID: 38282710 PMC: 10812137. DOI: 10.2147/JIR.S434720.


Identification of monocyte-associated pathways participated in the pathogenesis of pulmonary arterial hypertension based on omics-data.

Zhong C, Si Y, Yang H, Zhou C, Chen Y, Wang C Pulm Circ. 2023; 13(4):e12319.

PMID: 38130888 PMC: 10733707. DOI: 10.1002/pul2.12319.


References
1.
Shen Y, Kapfhamer D, Minnella A, Kim J, Won S, Chen Y . Bioenergetic state regulates innate inflammatory responses through the transcriptional co-repressor CtBP. Nat Commun. 2017; 8(1):624. PMC: 5608947. DOI: 10.1038/s41467-017-00707-0. View

2.
Savai R, Pullamsetti S, Kolbe J, Bieniek E, Voswinckel R, Fink L . Immune and inflammatory cell involvement in the pathology of idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med. 2012; 186(9):897-908. DOI: 10.1164/rccm.201202-0335OC. View

3.
Caputa G, Castoldi A, Pearce E . Metabolic adaptations of tissue-resident immune cells. Nat Immunol. 2019; 20(7):793-801. DOI: 10.1038/s41590-019-0407-0. View

4.
Mills E, ONeill L . Reprogramming mitochondrial metabolism in macrophages as an anti-inflammatory signal. Eur J Immunol. 2015; 46(1):13-21. DOI: 10.1002/eji.201445427. View

5.
Frid M, Brunetti J, Burke D, Carpenter T, Davie N, Reeves J . Hypoxia-induced pulmonary vascular remodeling requires recruitment of circulating mesenchymal precursors of a monocyte/macrophage lineage. Am J Pathol. 2006; 168(2):659-69. PMC: 1606508. DOI: 10.2353/ajpath.2006.050599. View